Moderate Exercise Can Boost Survival in CRC: Clin Onc News Report

Also, new model could help improve breast cancer care

As little as 30 minutes of moderate physical activity appears to improve progression-free and overall survival in patients with metastatic colorectal cancer, according to a recent study.

Knowing when it's appropriate for patients to receive radiation therapy after breast-conserving surgery for ductal carcinoma in situ is tricky. Prediction tools developed at Memorial Sloan Kettering Cancer Center in New York City may help oncologists decide.

Here's more on the prediction tools: A recent analysis found that the nomograms may help some patients avoid axillary lymph node dissection, making it potentially cost-effective.

When combined with ibrutinib, immunotherapies may become more effective in patients with chronic lymphocytic leukemia, new data revealed.

The immunotherapy drug pembrolizumab may improve overall survival and response rates in patients with previously treated advanced urothelial cancer compared to chemotherapy, according to a recent analysis.

Clin Onc News Report is brought to MedPage Today readers by our friends at Clinical Oncology News, a McMahon Group title. Registration (free) may be required for some content.